Hormone Therapy for Cancer in Thailand Your guide to cost, top specialists & hospitals

Our partner hospitals hold JCI accreditation and run comprehensive cancer centres with medical, surgical, and radiation oncology under one roof, alongside pathology and hormone-receptor testing. That means your diagnosis can be confirmed and your treatment chosen and started in one place, with the wider team reviewing your case.

Choosing and monitoring hormone therapy is the medical oncologist's job. Our partner oncologists are board-certified, follow international guidelines, and have experience managing international patients. They set out a written plan covering the drug, dose, duration, and monitoring so your treatment can continue smoothly after you travel home.

Look for JCI accreditation, a board-certified medical oncologist, and on-site pathology so hormone-receptor status can be confirmed. Just as important for a long-term treatment is a clear handover plan and a willingness to liaise with your home team, so there is no gap in your care once you leave.

Used after surgery for hormone-receptor-positive breast cancer or alongside other prostate treatment, hormone therapy lowers the risk of the cancer coming back. The benefit is not something you see; it is a long-term reduction in recurrence risk that builds over the years you take it, which is why completing the full course matters.

For advanced hormone-sensitive cancer, endocrine therapy can shrink a tumour and control the disease, sometimes for a long time, while keeping side effects more manageable than some other treatments. Response is followed with scans and blood tests, and no oncologist can promise a particular outcome, but many people do well on it for an extended period.

For hormone therapy, the quote covers the specialist oncology assessment, confirming your diagnosis and hormone-receptor status, and starting treatment with a clear written plan. In Thailand this typically runs from around $150 to $800 depending on the consultations, any tests repeated on arrival, and the first prescription or injection. Because the treatment continues for years, the long-term medication cost is separate and is usually arranged at home.

The biggest cost over time is the medication itself, taken for months or years and almost always continued where you live. Many hormone therapy tablets are widely available and relatively inexpensive as generics, while some injections cost more. This ongoing cost is not part of the assessment-and-initiation quote, and your home doctor or pharmacy usually supplies it.

The assessment cost depends on how many specialist consultations you need, whether pathology or hormone-receptor testing has to be repeated, and whether treatment starts with tablets or an injection. The ongoing medication cost depends on the specific drug, whether a generic is available, and how it is supplied at home.

Because hormone therapy is medication taken for years rather than a single procedure, the saving is not a dramatic one-off figure. It comes from a more affordable and faster specialist assessment, and from cheaper ongoing medication in many places, rather than from the visit itself. Request a free, no-obligation quote for a figure matched to your situation.

Hormone therapy is best understood as one part of a wider plan rather than a standalone alternative to other treatments. For hormone-sensitive cancers, it is usually combined with surgery, chemotherapy, or radiotherapy, and the oncology team decides which treatments to use and in what order.

After surgery for hormone-receptor-positive breast cancer, hormone therapy is often added to lower the risk of recurrence, sometimes after a course of chemotherapy. For prostate cancer, it is frequently given alongside radiotherapy or for disease that has spread. In each case it works with the other treatments, not instead of them.

It is worth being clear that hormone therapy and chemotherapy are different treatments that work in different ways, and they are sometimes used in sequence. Which combination is right depends on the cancer type, its stage, and your hormone-receptor status, all of which the multidisciplinary team weighs up when building your plan. The assessment visit is where that plan is set and the role of endocrine therapy within it is explained.

Almost always, yes. Hormone therapy runs for months to years, so a visit typically covers the specialist assessment and starting treatment, after which daily tablets or scheduled injections continue with a doctor where you live. You leave with a clear written plan, and your Thai oncologist stays reachable for remote review if your home team has questions.

Most side effects, such as hot flushes, joint aches, or tiredness, are manageable and often settle over time. Your team advises on managing them and, where helpful, can adjust the treatment. Bone-density loss is monitored with some agents and addressed if needed. Anything that does not settle should be reviewed by a doctor.

For early disease treated after surgery, hormone therapy lowers the risk of recurrence rather than producing a visible result, so the benefit is in the long-term reduction of risk. For advanced disease, response is followed with scans and blood tests over time, and the plan is adjusted accordingly.

The treatment is the same internationally licensed medication used at leading cancer centres worldwide, and at JCI-accredited hospitals in Thailand it is prescribed and monitored by board-certified medical oncologists. The key with a long-term treatment is continuity, which is why you leave with a clear written plan for ongoing care at home.

Effects that build over time, such as bone-density loss with aromatase inhibitors or androgen-deprivation therapy, are monitored with bone scans and managed with supplements or bone-protecting treatment where needed. Your plan sets out what monitoring is required so your home team can keep it up.

Long-term androgen-deprivation therapy for prostate cancer raises the risk of heart problems, metabolic syndrome, and higher cholesterol, so blood pressure, weight, blood sugar, and lipids are checked at baseline and followed over time. Your plan sets out these checks for your home team, and managing diet, activity, and any existing heart risk factors is part of staying well on treatment.

When an LHRH agonist injection is first given for prostate cancer, testosterone briefly surges for a week or two before it falls, which can temporarily worsen symptoms. In men with cancer that has spread to the bone this flare can increase bone pain or, rarely, press on the spinal cord, so an anti-androgen tablet is usually started first to cover it. Your oncologist plans the first injection and any cover, and factors this in before you travel home.

Some people notice memory or concentration difficulties, or mood changes and low mood, particularly with androgen-deprivation therapy and to a lesser extent with aromatase inhibitors. These are worth raising with your team, who can advise and review, as they often ease and can be managed alongside the rest of your care.

Yes. If side effects are difficult, the dose can sometimes be adjusted or a different agent used, for example switching between tamoxifen and an aromatase inhibitor. These decisions are standard oncology practice and balance keeping the cancer benefit against your quality of life.

Plan for a few days, enough for specialist consultations, any tests that need repeating, confirming your hormone-receptor status, and starting treatment. Unlike surgery, there is no recovery period to wait out. The one exception is prostate patients having a first LHRH agonist injection, where the oncologist may add anti-androgen cover and a short observation window before a long-haul flight to account for the brief testosterone flare. The treatment itself continues at home, so a short, focused visit is usually all that is needed to get started.

This is the most important part of the plan. You leave with a written summary covering the exact drug, dose, duration, and monitoring schedule, so your home doctor can supply ongoing tablets or give scheduled injections without interruption. Cross-border continuity and clear records are what make starting treatment abroad work safely.

We provide treatment summaries and a monitoring plan for your home medical team, and remote review with your Thai oncologist can be arranged if your local doctor wants to discuss the handover. The aim is a seamless transition so your long-term treatment carries on as planned.